Bladder Cancer

Latest News

UGN-101 associated with favorable long-term durability in low-grade UTUC
UGN-101 associated with favorable long-term durability in low-grade UTUC

February 12th 2025

The median duration of response was 47.8 months among patients who achieved an initial complete response.

Anktiva as a lymphocyte rescue molecule: Unlocking the power of NK cells and T cells
Anktiva as a lymphocyte rescue molecule: Unlocking the power of NK cells and T cells

February 6th 2025

Genomic subtyping may help predict clinical outcomes in bladder cancer
Genomic subtyping may help predict clinical outcomes in bladder cancer

February 5th 2025

US FDA logo in white over a blue background. | Credit: US Food and Drug Administration
FDA Updates in Urology: January 2025

February 4th 2025

Urologist speaking with a male patient following a diagnosis of cancer. | Credit: Adobe Stock
Urologic Cancer Facts and Updates for World Cancer Day 2025

February 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.